CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ·Healthcare·Biotechnology
$5.00
-1.38%
Mkt Cap $1.74M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
Implied Upside
-90.0%
Consensus $0.50 vs current $5.00
NASDAQ·Healthcare·Biotechnology
$5.00
-1.38%
Mkt Cap $1.74M
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
-90.0%
Consensus $0.50 vs current $5.00